Pontifax Management 4 G.P. (2015) Ltd. - Sep 12, 2025 SCHEDULE 13D Report for LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share

Filing Manager
Pontifax Management 4 G.P. (2015) Ltd.
Reporting Manager
Pontifax Management 4 G.P. (2015) Ltd.
Security
LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share
Shares outstanding
22.4M shares
Disclosed Ownership
1.41M shares
Ownership
6.3%
Form type
SCHEDULE 13D
Date filed
9/25/2025, 10:55 AM
Date of event
Sep 12, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Pontifax Management 4 G.P. (2015) Ltd. 6.3% 1.41M 0 1.41M /s/ Ran Nussbaum Ran Nussbaum Managing Partner 0001726334
Pontifax VI G.P. L.P. 6.3% 1.41M 0 1.41M /s/ Ran Nussmabum Ran Nussbaum Managing Partner
Ran Nussbaum 6.3% 1.41M 0 1.41M /s/ Ran Nussbaum Ran Nussbaum
Tomer Kariv 6.3% 1.41M 0 1.41M /s/ Tomer Kariv Tomer Kariv